These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 35433410)
21. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J Front Genet; 2023; 14():1087563. PubMed ID: 36861130 [No Abstract] [Full Text] [Related]
22. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer. Chen W; Zhang W; Zhou T; Cai J; Yu Z; Wu Z Int J Gen Med; 2021; 14():8109-8120. PubMed ID: 34803395 [TBL] [Abstract][Full Text] [Related]
23. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Ye Y; Dai Q; Qi H Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074 [TBL] [Abstract][Full Text] [Related]
24. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
25. Predicting the prognosis of glioma by pyroptosis-related signature. Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605 [TBL] [Abstract][Full Text] [Related]
26. Development of a Prognostic Model of Glioma Based on Pyroptosis-Related Genes. Niu X; Cheng R; Wang Y; Chen J; Wang C; Ji H World Neurosurg; 2022 Feb; 158():e929-e945. PubMed ID: 34861452 [TBL] [Abstract][Full Text] [Related]
27. A novel disulfide death-related genes prognostic signature identifies the role of IPO4 in glioma progression. Wu H; Yang Z; Chang C; Wang Z; Zhang D; Guo Q; Zhao B Cancer Cell Int; 2024 May; 24(1):168. PubMed ID: 38734657 [TBL] [Abstract][Full Text] [Related]
28. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma. Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM Front Immunol; 2022; 13():1027794. PubMed ID: 36389690 [TBL] [Abstract][Full Text] [Related]
29. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma. Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K Front Oncol; 2020; 10():1119. PubMed ID: 32974125 [No Abstract] [Full Text] [Related]
30. The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia. Sha Y; Jiang R; Miao Y; Qin S; Wu W; Xia Y; Wang L; Fan L; Jin H; Xu W; Li J; Zhu H Front Immunol; 2022; 13():939978. PubMed ID: 36177050 [TBL] [Abstract][Full Text] [Related]
31. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma. Li T; Liu H; Dong C; Lyu J Front Pharmacol; 2022; 13():806995. PubMed ID: 35153782 [No Abstract] [Full Text] [Related]
32. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma. Zhang X; Ping S; Wang A; Li C; Zhang R; Song Z; Gao C; Wang F Int J Gen Med; 2021; 14():8611-8620. PubMed ID: 34849006 [TBL] [Abstract][Full Text] [Related]
33. Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients. Tanzhu G; Li N; Li Z; Zhou R; Shen L Front Oncol; 2022; 12():779168. PubMed ID: 35237509 [TBL] [Abstract][Full Text] [Related]
34. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma. Li X; He J Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma. Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245 [TBL] [Abstract][Full Text] [Related]
36. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
37. A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma. Yu H; Fu Y; Tang Z; Jiang L; Qu C; Li H; Tan Z; Shu D; Peng Y; Liu S Aging (Albany NY); 2022 Jan; 14(2):989-1013. PubMed ID: 35085103 [TBL] [Abstract][Full Text] [Related]
38. A Novel Pyroptosis-Associated Gene Signature to Predict Prognosis in Patients with Colorectal Cancer. Dai J; Chen S; Bai Y; Fu Y; Pan Y; Ye L Evid Based Complement Alternat Med; 2022; 2022():6965308. PubMed ID: 35620407 [TBL] [Abstract][Full Text] [Related]
39. A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer. Qiu P; Guo Q; Pan K; Chen J; Lin J Front Oncol; 2022; 12():890242. PubMed ID: 36276158 [TBL] [Abstract][Full Text] [Related]
40. Construction of a Prognostic Gene Signature Associated with Immune Infiltration in Glioma: A Comprehensive Analysis Based on the CGGA. Gong X; Liu L; Xiong J; Li X; Xu J; Xiao Y; Li J; Luo X; Mao D; Liu L J Oncol; 2021; 2021():6620159. PubMed ID: 33790966 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]